Using long-acting injectable HIV treatment to help people released from jail stay healthy
Long-acting injectable antiretroviral treatment to improve HIV treatment among justice-involved persons being released to the community
This study is looking at how a special injectable HIV treatment given every four weeks can help people with HIV who are coming out of jail stay healthy and stick to their medication routine more easily.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miriam Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10894286 on NIH RePORTER |
What this research studies
This research investigates how long-acting injectable antiretroviral treatment can improve health outcomes for individuals with HIV who are being released from incarceration. It focuses on the critical period of community re-entry, where these individuals often struggle to adhere to daily oral medications. By administering an injectable treatment every four weeks, the study aims to enhance adherence and viral suppression. The research will involve developing and testing a tailored protocol for this population in collaboration with local public safety departments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with HIV who are being released from incarceration and may have difficulty adhering to daily medication regimens.
Not a fit: Patients who are not involved in the justice system or those who do not have HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and reduced HIV transmission among justice-involved individuals.
How similar studies have performed: Other research has shown promise in using long-acting injectable treatments for HIV, indicating potential for success in this novel application.
Where this research is happening
Providence, United States
- Miriam Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Beckwith, Curt G — Miriam Hospital
- Study coordinator: Beckwith, Curt G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.